Chronic HDV is considered the most severe form of viral hepatitis due to rapid disease progression towards liver failure and liver-related death –
– Approval introduces the first FDA-approved therapy for this disease with limited treatment options and high unmet need
Continue reading
For the second straight year, the University of Arizona College of Medicine – Phoenix hosted Research Week. The series of events, bridged between two weeks, served as a fantastic showcase for how the college and its partners are driving discovery and fueling the future of healthier Arizona.Continue reading
Global coalition unites NAMs developers to accelerate validation, qualification, and regulatory adoption of human-relevant methodologies, reducing reliance on animal models and improving the efficiency of drug development.Continue reading
Based in Scottsdale, Arizona, CND Life Sciences is a neurodegenerative disease diagnostics company dedicated to giving patients clarity sooner through minimally invasive, skin-based testing.
This spotlight is published in recognition of the World Parkinson Congress (WPC) taking place in Phoenix this May, a fitting moment to highlight the work of a company deeply committed to advancing care for patients with Parkinson’s and related neurodegenerative diseasesContinue reading
Christopher K. Finch, Pharm.D., FCCM, FCCP has been appointed dean of the R. Ken Coit College of Pharmacy, effective Aug. 1, following a collaborative and comprehensive national search that involved the broader campus community.Continue reading
His lab will focus on advancing immuno‑oncology and microbiome innovation and research on understanding and interrupting tumor–immune interactionsContinue reading
Dr. Nageatte Ibrahim helped guide the clinical development of Keytruda, one of the most consequential immuno-oncology therapiesContinue reading
HemaSense is developing a wearable device designed to give clinicians real-time visibility into what’s happening beneath the skin during post-procedural recovery, with a mission to accelerate recovery through actionable clinical insight.Continue reading
Dick Mallery was more that a business attorney. Passionate about the city he called home, a patron of the arts, and a champion for health innovation, Dick Mallery lived a life that crafted a lasting legacy.
JAYseq, a powerful new whole genome sequencing assay delivers a comprehensive, 72 hour molecular profile to help oncologists personalize care for patients across the myeloma disease spectrum